HEPATITIS C IN PATIENTS WITH TUMORS, PREVALENCE AND DIAGNOSTIC METHODS

*Khldoun Salah Aslan

ABSTRACT

Background: Numerous studies have proven that the correct treatment of Hepatitis c infection in patients with some types of tumors improves the prognosis of these tumors. The aim of the study: Titer the level of HCV antibodies in patients diagnosed with tumors and study the possible relationship between this infection and the incidence of these tumors. Materials and methods: This study included 64 patients who were diagnosed with different types of tumors before undergoing any treatment (chemotherapy, radiotherapy, hormonal therapy) between March 2021- October 2022 at Tishreen University Hospital, lattakia, Syria. Blood samples were taken to detect Hepatitis C infection in patients with tumors to study the relationship between them. Results: The study sample included 64 people, with 36 males (56.3%), and 28 females (43.7%) who were diagnosed with tumors before having any type of treatments with significant differences between the healthy and oncological groups in the distribution of HCV antibodies. So that, we can say that there is an association between hepatitis C infection and different types of tumors, but we cannot say for sure that HCV infection will inevitably lead to a tumor.

Keywords: Cancer, tumors, Hepatitis C, ELISA, HCV Antibodies.